<SEC-DOCUMENT>0001193125-16-635549.txt : 20160629
<SEC-HEADER>0001193125-16-635549.hdr.sgml : 20160629
<ACCEPTANCE-DATETIME>20160629081656
ACCESSION NUMBER:		0001193125-16-635549
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160629
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160629
DATE AS OF CHANGE:		20160629

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		161737341

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d192204d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form&nbsp;8-K
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): June&nbsp;29, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>McKesson Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>1-13252</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94-3207296</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>One Post Street, San Francisco, California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>94104</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip&nbsp;Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (415)&nbsp;983-8300 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report.) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 29, 2016, in connection with its Investor Day in Boston,
Massachusetts, McKesson Corporation (the &#147;Company&#148;) issued a press release updating its earnings guidance for the fiscal year ending March 31, 2017. A copy of the Company&#146;s press release is attached hereto as Exhibit 99.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Form 8-K, including Exhibit 99.1, is furnished to the Securities and Exchange Commission (the &#147;Commission&#148;), but
shall not be deemed &#147;filed&#148; with the Commission for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit&nbsp;No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release issued by the Company dated June 29, 2016.</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: June&nbsp;29, 2016 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>McKesson Corporation</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James A. Beer</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">James A. Beer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President and</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit&nbsp;No.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release issued by the Company dated June 29, 2016.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d192204dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g192204logo.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MCKESSON UPDATES FISCAL 2017 GUIDANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SAN FRANCISCO, June&nbsp;29, 2016</B>&#151;McKesson Corporation (NYSE:MCK) today announced that for the fiscal year ending March&nbsp;31, 2017, the company
has updated its previous guidance range of $13.30 to $13.80 per diluted share to a new range of $13.43 to $13.93 per diluted share, which continues to exclude approximately 12 to 15 cents in expected charges from Adjusted Earnings related to the
Cost Alignment Plan the company announced in March 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The updated outlook is driven by the early adoption of Accounting Standards Update 2016-09 as
released by the Financial Accounting Standards Board, which relates to stock-based compensation, and the impact of foreign currency exchange effects, specifically related to British pound sterling-denominated activity. The change in accounting for
stock-based compensation will drive an increase of approximately twenty cents per diluted share in Fiscal 2017, offset by approximately seven cents per diluted share in incremental impact from our original assumption related to foreign currency
exchange effects. Excluding these two items, the underlying key Fiscal 2017 assumptions provided in McKesson&#146;s press release on May&nbsp;4, 2016 are unchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">McKesson is hosting its Investor Day today in Boston, Massachusetts. A webcast of the presentation is available through McKesson&#146;s website,
<U>www.mckesson.com</U>, live from 9:00 AM to 1:00 PM ET today and on replay afterwards. Shareholders are encouraged to review McKesson&#146;s SEC reports, which are available at <U>www.mckesson.com</U> under the &#147;Investors&#148; tab. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for historical information contained
in this press release, matters discussed may constitute &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, that involve
risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These statements may be identified by their use of forward-looking terminology such as &#147;believes&#148;,
&#147;expects&#148;, &#147;anticipates&#148;, &#147;may&#148;, &#147;will&#148;, &#147;should&#148;, &#147;seeks&#148;, &#147;approximately&#148;, &#147;intends&#148;, &#147;plans&#148;, &#147;estimates&#148; or the negative of these words or other
comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. It is not possible to predict or identify all such risks and uncertainties; however, the most significant of these
risks and uncertainties are described in the company&#146;s Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission and include, but are not limited to: changes in the U.S. healthcare industry and regulatory
environment; managing foreign expansion, including the related operating, economic, </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
political and regulatory risks; changes in the Canadian healthcare industry and regulatory environment; exposure to European economic conditions, including recent austerity measures taken by
certain European governments; changes in the European regulatory environment with respect to privacy and data protection regulations; fluctuations in foreign currency exchange rates; the company&#146;s ability to successfully identify, consummate,
finance and integrate acquisitions; the company&#146;s ability to manage and complete divestitures; material adverse resolution of pending legal proceedings; competition and industry consolidation; substantial defaults in payment or a material
reduction in purchases by, or the loss of, a large customer or group purchasing organization; the loss of government contracts as a result of compliance or funding challenges; public health issues in the U.S. or abroad; cyberattack, natural
disaster, or malfunction of sophisticated internal computer systems to perform as designed; the adequacy of insurance to cover property loss or liability claims; the company&#146;s failure to attract and retain customers for its software products
and solutions due to integration and implementation challenges, or due to an inability to keep pace with technological advances; the company&#146;s proprietary products and services may not be adequately protected, and its products and solutions may
be found to infringe on the rights of others; system errors or failure of our technology products or services to conform to specifications; disaster or other event causing interruption of customer access to data residing in our service centers; the
delay or extension of our sales or implementation cycles for external software products; changes in circumstances that could impair our goodwill or intangible assets; new or revised tax legislation or challenges to our tax positions; general
economic conditions, including changes in the financial markets that may affect the availability and cost of credit to the company, its customers or suppliers; changes in accounting principles generally accepted in the United States of America;
withdrawal from participation in multiemployer pension plans or if such plans are reported to have underfunded liabilities; inability to realize the expected benefits from the company&#146;s restructuring and business process initiatives;
difficulties with outsourcing and similar third party relationships; risks associated with the company&#146;s retail expansion; and the company&#146;s inability to keep existing retail store locations or open new retail locations in desirable
places. The reader should not place undue reliance on forward-looking statements, which speak only as of the date they are first made. Except to the extent required by law, the company undertakes no obligation to publicly release the result of any
revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About McKesson Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">McKesson Corporation,
currently ranked 5th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical
companies, and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that
include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit <U>www.mckesson.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig Mercer, 415-983-8391 (Investors and Financial Media) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Craig.Mercer@McKesson.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kris Fortner, 415-983-8352 (General
and Business Media) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kris.Fortner@McKesson.com </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g192204logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g192204logo.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MI'FGPI=D\?V@!P&BD!]_EKT,6OW9YV!?[U%KXP?\CLO_ %ZI_,U&"_AE8_\
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MS/?6BL/I#"@ I( I@% @H&% "T@$I@% D% PH *!!0,* "@ H 6@!#0 4 %
?"T )WH#H+0 E "T )WH *.H!0(*!BT (* $-!+/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
